Generic name: HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) 720[iU] in 0.5mL
Dosage form: injection, suspension
Medically reviewed on January 22, 2018.
Preparation for Administration
Shake vial or syringe well before withdrawal and use. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If either of these conditions exists, the vaccine should not be administered. With thorough agitation, HAVRIX is a homogeneous, turbid, white suspension. Do not administer if it appears otherwise.
Recommended Dose and Schedule
HAVRIX should be administered by intramuscular injection only. HAVRIX should not be administered in the gluteal region; such injections may result in suboptimal response.
Children and Adolescents: Primary immunization for children and adolescents (12 months through 18 years of age) consists of a single 0.5-mL dose and a 0.5-mL booster dose administered anytime between 6 and 12 months later in order to ensure the highest antibody titers. The preferred sites for intramuscular injections are the anterolateral aspect of the thigh in infants and young children or the deltoid muscle of the upper arm in older children.
Adults: Primary immunization for adults consists of a single 1-mL dose and a 1-mL booster dose administered anytime between 6 and 12 months later in order to ensure the highest antibody titers. In adults, the injection should be given in the deltoid region.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Havrix (hepatitis a adult vaccine)
- Havrix Side Effects
- During Pregnancy
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- Drug class: viral vaccines
Other brands: Vaqta